drugset / Trial / NCT07304518
Phase II Trial of PRT-064040 Nasal Spray for the Treatment of Migraine in Adults
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to learn about the efficacy and safety of PRT-064040 Nasal Spray versus placebo in the acute treatment of moderate or severe migraine.
Timeline
- Start
- 2026-01-26
- Primary completion
- 2026-09
- Completion
- 2026-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PRT-064040 | Unknown | — | Intranasal |